ALK and non-small cell lung carcinoma: Subsequently, each pathophysiological process was functionally characterized at protein level to determine its molecular effectors and used for focusing the analysis towards ALK+ NSCLC in a human biological network context (Figure 1 and Supplementary Table 2).